Macular holes: Vitreoretinal relationships and surgical approaches

Eye

Volumn 22, Issue 10, 2008, Pages 1301-1309

  Bainbridge, J ^a   Herbert, E ^b   Gregor, Z ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b MUSGROVE PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INDOCYANINE GREEN; TRYPAN BLUE;

CLINICAL TRIAL; CONFERENCE PAPER; DISEASE ASSOCIATION; HUMAN; INTRAOCULAR PRESSURE; LOW DRUG DOSE; OPTICAL COHERENCE TOMOGRAPHY; PATHOGENESIS; PATIENT POSITIONING; PIGMENT EPITHELIUM; PROGNOSIS; RETINA MACULA HOLE; SURGICAL APPROACH; SURGICAL TECHNIQUE; VISUAL ACUITY; VISUAL FIELD DEFECT; VITRECTOMY; VITREOUS BODY DETACHMENT;

EID: 54249156981     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.23     Document Type: Conference Paper

References (87)

1. Evans JR, Schwartz SD, McHugh JD, Thamby-Rajah Y, Hodgson SA, Wormald, RP et al. Systemic risk factors for idiopathic macular holes: A case-control study. Eye 1998; 12(Part 2): 256-259.
2. Kang HK, Chang AA, Beaumont PE. The macular hole: Report of an Australian surgical series and meta-analysis of the literature. Clin Experiment Ophthalmol 2000, 28(4). 298-308.
3. Polk TD, Smiddy WE, Flynn Jr HW. Bilateral visual function after macular hole surgery. Ophthalmology 1996; 103(3): 422-426.
4. Smiddy WE, Pimentel S, Williams GA. Macular hole surgery without using adjunctive additives. Ophthalmic Surg Lasers 1997; 28(9): 713-717.
5. Margherio M Margherio AR, Williams GA, Chow DR, Banach MJ. Effect of perifoveal tissue dissection in the management of acute idiopathic full-thickness macular holes. Arch Ophthalmol 2000; 118(4): 495-498.
6. Brooks Jr HL. Macular hole surgery with and without internal limiting membrane peeling. Ophthalmology 2000; 107(10):1939-1948; discussion 1948-1939.
7. Lai MM, Williams GA. Anatomical and visual outcomes of idiopathic macular hole surgery with internal limiting membrane removal using low-concentration indocyanine green. Retina 2007; 27(4): 477-482.
8. Morgan CM, Schatz H. Involutional macular thinning: A pre-macular hole condition. Ophthalmology 1986, 93(2): 153-161.
9. Gaudric A, Haouchine B, Massin P, Paques M, Blain P, Erginay A. Macular hole formation: New data provided by optical coherence tomography. Arch Ophthalmol 1999, 117(6): 744-751.
10. Azzolini C, Patelli F, Brancato R Correlation between optical coherence tomography data and biomicroscopic interpretation of idiopathic macular hole. Am J Ophthalmol 2001; 132(3): 348-355.
11. Tanner V, Chauhan DS, Jackson TL, Williamson TH. Optical coherence tomography of the vitreoretinal interface in macular hole formation. Br J Ophthalmol 2001; 85(9): 1092-1097.
12. Gass JD. Idiopathic senile macular hole. Its early stages and pathogenesis. Arch Ophthalmol 1988; 106(5): 629-639.
13. Lewis ML, Cohen SM, Smiddy WE, Gass JD. Bilaterality of idiopathic macular holes. Graefes Arch Clin Exp Ophthalmol 1996; 234 (4): 241-245.
14. Ezra E. Idiopathic full thickness macular hole: Natural history and pathogenesis. Br J Ophthalmol 2001; 85(1): 102-108.
15. Gass JD. Muller cell cone, an overlooked part of the anatomy of the fovea centralis: Hypotheses concerning its role in the pathogenesis of macular hole and foveomacualr retinoschisis. Arch Ophthalmol 1999; 117(6): 821-823.
16. Kim JW, Freeman WR, el-Haig W, Maguire AM, Arevalo JF, Azen SP. Baseline characteristics, natural history, and risk factors to progression in eyes with stage 2 macular holes. Results from a prospective randomized clinical trial. Vitrectomy for Macular Hole Study Group. Ophthalmology 1995; 102(12): 1818-1828; discussion 1028-1819.
17. Madreperla SA, Geiger GL, Funata M, de la Cruz Z, Green WR. Clinicopathologic correlation of A macular hole treated by cortical vitreous peeling and gas tomponade. Ophthalmology 1994; 101 (4): 682-686.
18. GasU JD. Macular hole opercula: Ultras: ultrastructural features and clinicopathologic correlation. Arch Ophthalmol 1998, 116 (7): 965-966.
19. Ezra E, Munro PM, Charteris DG, Aylward WG, Luthert PJ, Gregor ZJ. Macular hole opercula. Ultrastructural features and clinicopathological correlation. Arch Ophthalmol 1997; 115(11): 1381-1387.
20. Tanner V, Williamson TH. Watzke-Allen slit beam test in macular holes confirmed by optical coherence tomography. Arch Ophthalmol 2000; 118(8): 1059-1063.
21. Tornambe PE. Macular hole genesis: The hydration theory. Retina 2003; 23(3): 421-424.
22. Ezra E, Gregor ZJ. Surgery for idiopathic full-thickness macular hole: two-year results of a randomized clinical trial comparing natural history, vitrectom, and vitrectomy plus autologous serum: Morfields Macular Hole Study Group RAeport no. 1. Arch Ophthalmol 2004; 122(2): 224-236.
23. Haouchine B, Massin P, Gaudric A. Foveal pseudocyst as the first step in macular hole formation: A prospective study by optical coherence tomography. 0phthalmology 2001; 108(1): 15-22.
24. Johnson RN, McDonald M Lewis H, Grand MG, Murray TG, Mieler WF et al Traumatic macular hole: Observations, pathogenesis, and results of vitrectomy surgery. Ophthalmology 2001; 108(5): 853-857.
25. Yamashita T. Uemara A, Uchino E, Doi N, Ohba N. Spontaneous closure of traumatic macular hole. Am J Ophthalmol 2002; 133(2): 230-235.
26. Hee MR, Puliafito CA, Wong C, Duker JS, Reichel E, Schuman JS et al Optical coherence tomography of macular holes. Ophthalmology 1995; 102(5): 748-756.
27. Apostolopoulos MN, Koutsandrea CN, Moschos MN, Alonistiotis DA, Papaspyrou AE, Mallias JA et al. Evaluation of successful macular hole surgery by optical coherence tomography and multifocal electroretinography. Am J Ophthalmol 2002; 134(5): 667-674.
28. Kusuhara S, Teraoka Escano MF, Fujii S, Nakanishi Y, Tamura Y, Nagai A et al. Prediction of postoperative visual outcome based on hole configuration by optical coherence tomography in eyes with idiopathic macular holes. Am J Ophthalmol 2004; 138(5): 709-716.
29. Ko TH, Fujimoto JG, Schuman JS, Paunescu LA, Kowalevicz AM, Hartl I et al. Comparison of ultrahigh- and standard-resolution optical coherence tomography for imaging macular pathology. Ophthalmology 2005; 112(11): 1922.
30. Hangai M, Ojima Y, Gotoh N, Inoue R, Yasuno Y, Makita S et al. Three-dimensional imaging of macular holes with high-speed optical coherence tomography. Ophthalmology 2007; 114(4): 763-773.
31. Kelly NE, Wendel RT. Vitreous surgery for idiopathic macular holes. Results of a pilot study. Arch Ophthalmol 1991; 109(5): 654-659.
32. de Bustros S. Vitrectomy for prevention of macular holes. Results of a randomized multicenter clinical trial. Vitrectomy for Prevention of Macular Hole Study Group. Ophthalmology 1994; 101(6): 1055-1059; discussion 1060.
33. Wendel RT, Patel AC, Kelly NE, Salzano TC, Wells JW, Novack GD. Vitreous surgery for macular holes. Ophthalmology 1993; 100(11): 1671-1676.
34. Kim JW, Freeman WR, Azen SP, el-Haig W, Klein DJ, Bailey IL. Prospective randomized trial of vitrectomy or observation for stage 2 macular holes. Vitrectomy for Macular Hole Study Group. Am J Ophthalmol 1996; 121(6): 605-614.
35. Freeman WR, Azen SP, Kim JW, el-Haig W, Mishell III DR, Bailey I. Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes. Results of a multicentered randomized clinical trial. The Vitrectomy for Treatment of Macular Hole Study Group. Arch Ophthalmol 1997; 115(1): 11-21.
36. Thompson JT, Glaser BM, Sjaarda RN, Murphy RP, Hanham A. Effects of intraocular bubble duration in the treatment of macular holes by vitrectomy and transforming growth factor-beta 2. Ophthalmology 1994; 101(7): 1195-1200.
37. Thompson JT, Smiddy WE, Glaser BM, Sparda RN, Flynn Jr HW. Intraocular tamponade duration and success of macular hole surgery. Retina 1996; 16(5): 373-382.
38. Mulhern MG, Cullinane A, Cleary PE. Visual and anatomical success with short-term macular tamponade and autologous platelet concentrate. Graefes Arch Clin Exp Ophthalmol 2000; 238(7): 577-583.
39. Park DW, Sipperley JO, Sneed SR, Dugel PU, Jacobsen J. Macular hole surgery with internal-limiting membrane peeling and intravitreous air. Ophthalmology 1999; 106(7): 1392-1397; discussion 1397-1398.
40. Tornambe PE, Poliner IS, Grote K. Macular hole surgery without face-down positioning. A pilot study. Retina 1997; 17(3): 179-185.
41. Simcock M Scalia S. Phacovitrectomy without prone posture for full thickness macular holes. Br J Ophthalmol 2001; 85(11): 1316-1319.
42. Goldbaum MH, McCuen BW, Hanneken AM, Burgess SK, Chen HH. Silicone oil tamponade to seal macular holes without position restrictions. Ophthalmology 1998, 105(11): 2140-2147; discussion 2147-2148.
43. Karia N, Laidlaw A, West J, Ezra E, Gregor MZ. Macular hole surgery using silicone oil tamponade. Br J Ophthalmol 2001; 85(11): 1320-1323.
44. Pertile G, Claes C. Silicone oil vs gas for the treatment of full-thickness macular hole. Bull Soc Belge Ophtalmol 1999; 274 31-36.
45. Schwatz SD, Alexander R, Hiscott P, Gregor ZJ. Recognition of vitreoschisis in proliferative diabetic retinopathy. A useful landmark in vitrectomy for diabetic traction retinal detachment. Ophthalmology 1996, 103(2): 323-328.
46. Hisatomi T, Enaida H, Sakamoto T, Kagimoto T, Ueno A, Nakamura T et al. A new method for comprehensive bird's-eye analysis of the surgically excised internal limiting membrane. Am J Ophthalmol 2005; 139(6): 1121-1122.
47. Foulquier S, Glacet-Bernard A, Sterkers K Soubrane G, Coscas G. Study of internal limiting membrane peeling in stage-3 and -4 idiopathic macular hole surgery]. J Fr Ophtalmol 2002; 25(10): 1026-1031.
48. Sheidow TG, Blinder KJ, Holekamp N, Joseph D, Shah G, Grand MG et al Outcome results in macular hole surgery: An evaluation of internal limiting membrane peeling with and without indocyanine green. Ophthalmology 2003; 110(9): 1697-1701.
49. Al-Abdulla NA, Thompson JT, Sjaarda RN. Results of macular hole surgery with and without epiretinal dissection or internal limiting membrane removal. Ophthalmology 2004; 111(1): 142-149.
50. Smiddy WE, Feuer W, Cordahi G. Internal limiting membrane peeling in macular hole surgery. Ophthalmology 2001; 108(8): 1471-1476; discussion 1477-1478.
51. Haritoglou C, Gass CA, Schaumberger K Gandorfer A, Ulbig MW, Kampik A. Long-term follow-up after macular hole surgery with internal limiting membrane peeling. Am J Ophthalmol 2002; 134(5): 661-666.
52. Karacorlu M, Karacorlu S, Ozdemir H. Iatrogenic punctate chorioretinopathy after internal limiting membrane peeling. Am J Ophthalmol 2003; 135(2): 178-182.
53. Terasaki H, Miyake Y, Nomura R, Piao CH, Hori K, Niwa T et al. Focal macular ERGs in eyes after removal of macular ILM during macular hole surgery. Invest Ophthalmol Vis Sci 2001; 42(1): 229-234.
54. Tadayoni R, Gaudric A, Haouchine B, Massin P. Relationship between macular hole sin and the potential benefit of internal limiting membrane peeling. Br J Ophthalmol 2006; 90 (10): 1239-1241.
55. Banker AS, Freeman WR, Kim JW, Munguia D, Azen SP. Vision-threatening complications of surgery for full-thickness macular holes. Vitrectomy for Macular Hole Study Group. Ophthalmology 1997; 104(9): 1442-1452; discussion 1452-1443.
56. Da Mata AP, Burk SE, Riemann Rosa Jr RH, Snyder ME, Petersen MR et al Indocyanine green-assisted peeling of the retinal internal limiting membrane during vitrectomy surgery for macular hole repair. Ophthalmology 2001; 108(7): 1187-1192.
57. Van De Moere A, Stalmans P. Anatomical and visual outcome of macular hole surgery with infracyanine green-assisted peeling of the internal limiting membrane, endodrainage, and silicone oil tamponade. Am J Ophthalmol 2003, 136(5): 879-887.
58. Wolf S, Reichel MB, Wiedemann P, Schnurrbusch UE. Clinical findings in macuar hole surgery with indocyanine green-assisted peeling of the internal limiting membrane. Graefes Arch Clin Exp Ophthalmol 2003; 241(7): 589-592.
59. Lochhead J, Jones E, Chui D, Lake S, Karia N, Patel CK et al. Outcome of ICG-assisted ILM peel in macular hole surgery. Eye 2004; (8): 804-808.
60. Haritoglou C, Gandorfer A, Gass CA, Schaumberger M, Ulbig MW, Kampik A. Indocyanine green-assisted peeling of the internal limiting membrane in macular hole surgery affects visual outcome: A clinicopathologic correlation. Am J Ophthalmol 2002; 134(6): 836-841.
61. Gass CA, Haritoglou C, Schaumberger M, Kampik A. Functional outcome of macular hole surgery with and without indocyanine green-assisted peeling of the internal limiting membrane. Graefes Arch Clin Exp Ophthalmol 2003; 241(9): 716-720.
62. Engelbrecht NE, Freeman J, Sternberg Jr P, Aaberg Sr TM, Aaberg Jr TM, Martin DF et al. Retinal pigment epithelial changes after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol 2002; 133(1): 89-94.
63. Ando F, Sasano K, Ohba N, Hirose H, Yasui O. Anatomic and visual outcomes after mdocyanine green-assisted peeling of the retinal internal limiting membrane in idiopathic macular hole surgery. Am J Ophthalmol 2004; 137(4): 609-614.
64. Gandorfer A, Hantoglou C, Gass CA, Ulbig MW, Kampik A. Indocyanine green-assisted peeling of the internal limiting membrane may cause retinal damage. Am J Ophthalmol 2001; 132(3): 431-433.
65. Nakamura T, Murata T, Hisatomi T, Enaida H, Sassa Y, Ueno A et al. Ultrastructure of the vitreoretinal interface following the removal of the internal limiting membrane using indocyanine green. Curr Eye Res 2003; 27(6): 395-399.
66. Heij EC, Dieudonne SC, Mooy CM, Diederen RM, Liem AT, van Suylen RJ et al. Immunohistochemical analysis of the internal limiting membrane peeled with infracyanine green. Am J Ophthalmol 2005; 140 (6): 1123-1125.
67. Lee JE, Yoon TJ, Oum BS, Lee JS, Choi HY. Toxicity of indocyanine green injected into the subretinal space: Subretinal toxicity of indocyanine green. Retina 2003, 23(5): 675-681.
68. Sippy BD, Engelbrecht NE, Hubbard GB, Moriarty SE, Jiang S, Aaberg Jr TM et al. Indocyanine green effect on cultured human retinal pigment epithelial cells: Implication for macular hole surgery. Am J Ophthalmol 2001; 132(3): 433-435.
69. Gandorfer A, Haritoglou C, Kampik A. Retinal damage from indocyanine green in experimental macular surgery. Invest Ophthalmol Vis Sci 2003, 44(1): 316-323.
70. Ando F, Sasano K Suzuki F, Ohba N. Indocyanine green-assisted ILM peeling in macular hole surgery revisited. Am J Ophthalmol 2004; 138(5): 886-887.
71. Lai CC, Wu WC, Chuang LH, Yeung L, Chen TL, Lin KK. Prevention of indocyanine green toxicity on retinal pigment epithelium with whole blood in stain-assisted macular hole surgery. Ophthalmology 2005; 112(8): 1409-1414.
72. Li K, Wong D, Hiscott P, Stanga P, Groenewald C, McGalliard J. Trypan blue staining of internal limiting membrane and epiretinal membrane during vitrectomy: Visual results and histopathological findings. Br J Ophthalmol 2003; 87(2): 216-219.
73. Teba FA, Mohr A, Eckardt C, Wong D, Kusaka S, Joondeph BC et al. Trypan blue staining in vitreoretinal surgery. Ophthalmology 2003, 110(12): 2409-2412.
74. Perrier M, Sebag M. Trypan blue-assisted peeling of the internal limiting membrane during macular hole surgery. Am J Ophthalmol 2003; 135(6): 903-905.
75. Beutel J, Dahmen G, Ziegler A, Hoerauf H. Internal limiting membrane peeling with indocyanine green or trypan blue in macular hole surgery: A randomized trial. Arch Ophthalmol 2007, 125(3): 326-332.
76. Leonard II RE, Smiddy WE, Flynn Jr HW, Feuer W. Longterm visual outcomes in patients with successful, macular hole surgery. Ophthalmology 1997; 104(10): 1648-1652.
77. Takahashi H, Kishi S. Tomographic features of early macular hole closure after vitreous surgry. Am J Ophthalmol 2000; 130(2): 192-196.
78. Privat E, Thdayoni R, Gaucher D, Haouchine B, Massin P, Gaudric A. Residual defect in the foveal photoreceptor layer detected by optical coherence tomography in eyes with spontaneously dosed macular holes. Am J Ophthalmol 2007; 143(5):814-819.
79. Jaycock PD, Bunce C, Xing W, Thomas D, Poon W, Gazzard G et al. Outcomes of macular hole surgery: Implications for surgical management and clinical governance. Eye 2005; 19(8): 879-884.
80. Scott RA, Ezra E, West JF, Gregor ZJ. Visual and anatomical results of surgery for long standing inacular holes. Br J Ophthalmol 2000; 84(2): 150-153.
81. Stec LA, Ross RD, Williams GA, Trese MT, Margherio RR, Cox Jr MS. Vitrectomy for chronic macular holes. Retina 2004; 24(3): 341-347.
82. Tabandeh H, Smiddy WE, Mello M, Alexandrakis G, Flynn Jr HW, Gregor Z et al. Surgery for idiopathic macular holes associated with extensive subretinal fluid. Retina 2001; 21(1): 15-19.
83. Ezra E, Aylward WG, Gregor ZJ. Membranectomy and autologous serum for the retreatment of full-thickness macular holes. Arch Ophthalmal 1997, 115(10): 1276-1280.
84. Imai M, Gotoh T, Iijima H. Additional intravitreal gas injection in the early postoperative period for an unclosed macular hole treated with internal limiting membrane peeling. Retina 2005, 25(2): 158-161.
85. Kadonosono K, Yabuki K, Nishide T, Uchio E, Marron JA. Measured visual acuity of fellow eyes as a prognostic factor in macular hole surgery. Am J Ophthalmol 2003, 135(4): 493-498.
86. Mireskandari K, Garnham L, Sheard R, Ezra E, Gregor ZJ, Sloper JJ. A prospective study of the effect of a unilateral macular hole on sensory and motor binocular function and recovery following successful surgery. Br J Ophthalmol 2004; 88(10): 1320-1324.
87. Tranos PG, Ghazi-Nouri SM, Rubin GS, Adams ZC, Charteris DG. Visual function and subjective perception of visual ability after macular hole surgery. Am J Ophthalmol 2004; 138(6): 995-1002.